Home › Type 2 Diabetes › Arizona › Tucson
Pag-aaral pangklinika para sa Type 2 Diabetes sa Tucson, AZ
Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tucson. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Nagre-recruitPhase 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Arizona Clinical Trials, Tucson
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Noble Clinical Research, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Tucson Clinical Research Institute, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
- Arizona Clinical Trials, Tucson
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Nagre-recruitPhase 2
- Arizona Clinical Trials - Broadway, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Nagre-recruitPhase 2
- Pima Heart, Tucson
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Nagre-recruitPhase 3
- University of Arizona, Tucson
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL24 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL19 pag-aaral
- Chicago, IL19 pag-aaral
- Dallas, TX19 pag-aaral
- Columbus, OH18 pag-aaral
- Las Vegas, NV18 pag-aaral
- Atlanta, GA17 pag-aaral
- San Diego, CA17 pag-aaral
- Los Angeles, CA16 pag-aaral
Iba pang pag-aaral sa Tucson
- Kanser sa Suso20 pag-aaral
- Non-Small Cell Lung Cancer17 pag-aaral
- Obesity17 pag-aaral
- Overweight15 pag-aaral
- Metastatic Cancer14 pag-aaral
- Kanser (lahat ng uri)12 pag-aaral
- Sakit sa Puso at Ugat ng Dugo12 pag-aaral
- Colorectal Cancer11 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Steatotic Liver Disease10 pag-aaral
- Pagkabigo ng Puso10 pag-aaral
- Mataas na Presyon ng Dugo10 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.